Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes.
about
Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?Elevation in systolic blood pressure during heart failure hospitalization is associated with increased short and long-term mortality.Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.Targeting the mineralocorticoid receptor in cardiovascular disease.Treatment of acute heart failure in the emergency department.The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.Mineralocorticoid Receptor Antagonism in Acute Heart Failure.Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.Evaluation of a Pharmacist-Driven Aldosterone Antagonist Stewardship Program in Patients With Heart Failure.Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure.Lessons learned in acute heart failure.Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease
P2860
Q35272248-5835DA25-1C38-43E9-81CF-E88DF6DBAC5EQ37626578-683989AF-66D2-42D0-AEEC-96C792D018F3Q38040730-BE2B78BF-C10B-4262-B162-8A36EEF464C4Q38074488-6F98C940-555D-4015-90CC-A05BD2D61A20Q38145265-F3428B37-0B0B-4C44-9E2F-091289FE0493Q38766590-4F1D7734-122E-4BAD-98A0-1599D571682CQ39024503-0C708987-24FE-4817-A80A-CC16AE3E37B4Q39199991-56E63698-C840-4E4A-8ED0-5A88F3DA1DB4Q39224155-311C9818-1220-452D-9D97-D74E3BBEFBC0Q40710330-85624C77-FD25-409E-92AD-88F2E135F417Q41090275-FAB6A518-4BBB-4E4E-9EAD-F311FD3B4D87Q47323152-411C532E-B3D9-429B-AC73-CE3AE1347E37Q50047461-F65D7E7E-3FE5-4813-B89E-26B100B964E9Q52994251-1C91AC5F-55F9-45A4-995C-23BE150D4E86Q57911462-849A59F8-E326-4F56-A2ED-5E34C639B792
P2860
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@en
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@nl
type
label
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@en
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@nl
prefLabel
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@en
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@nl
P2860
P356
P1476
Mineralocorticoid receptor ant ...... acute heart failure syndromes.
@en
P2093
Mazen Albaghdadi
P2860
P304
P356
10.1093/EURHEARTJ/EHR170
P577
2011-06-14T00:00:00Z